药品注册申请号:019339
申请类型:NDA (新药申请)
申请人:HOSPIRA
申请人全名:HOSPIRA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 5,000 UNITS/100ML No No None 1985/03/27 1985/03/27 Prescription
002 HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML No No AP 1985/03/27 Prescription
003 HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML No No AP 1985/03/27 Prescription
004 HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 5,000 UNITS/100ML No No AP 1985/03/27 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/02/07 SUPPL-68(补充) Approval Labeling STANDARD
2019/09/04 SUPPL-52(补充) Approval Labeling STANDARD
2018/12/20 SUPPL-62(补充) Approval Labeling STANDARD
2014/03/13 SUPPL-54(补充) Approval Labeling STANDARD
2013/02/08 SUPPL-50(补充) Approval Manufacturing (CMC) STANDARD
2011/12/23 SUPPL-47(补充) Approval Labeling STANDARD
2009/07/23 SUPPL-38(补充) Approval Labeling STANDARD
2008/10/17 SUPPL-34(补充) Approval Labeling STANDARD
2002/11/07 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1999/11/19 SUPPL-24(补充) Approval Labeling STANDARD
1998/10/27 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1998/10/27 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1998/05/27 SUPPL-19(补充) Approval Labeling STANDARD
1998/03/16 SUPPL-21(补充) Approval Labeling STANDARD
1997/06/09 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
1996/08/30 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1996/02/07 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
1995/08/24 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
1995/08/22 SUPPL-15(补充) Approval Manufacturing (CMC) STANDARD
1994/11/10 SUPPL-14(补充) Approval Manufacturing (CMC) STANDARD
1994/11/10 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1994/11/10 SUPPL-12(补充) Approval Manufacturing (CMC) STANDARD
1994/11/10 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
1992/02/25 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
1992/02/18 SUPPL-8(补充) Approval Manufacturing (CMC) STANDARD
1990/02/16 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1986/10/29 SUPPL-4(补充) Approval Manufacturing (CMC) STANDARD
1986/09/24 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1986/08/03 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
1986/04/01 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1985/03/27 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:HEPARIN SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:10,000 UNITS/100ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019339 002 NDA HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML Prescription No No AP 1985/03/27 HOSPIRA
019339 003 NDA HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML Prescription No No AP 1985/03/27 HOSPIRA
019952 005 NDA HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML Prescription Yes Yes AP 1992/07/20 B BRAUN
活性成分:HEPARIN SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:10,000 UNITS/100ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019339 002 NDA HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML Prescription No No AP 1985/03/27 HOSPIRA
019339 003 NDA HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML Prescription No No AP 1985/03/27 HOSPIRA
019952 005 NDA HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 10,000 UNITS/100ML Prescription Yes Yes AP 1992/07/20 B BRAUN
活性成分:HEPARIN SODIUM 剂型/给药途径:INJECTABLE;INJECTION 规格:5,000 UNITS/100ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
019339 004 NDA HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 5,000 UNITS/100ML Prescription No No AP 1985/03/27 HOSPIRA
019952 004 NDA HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER HEPARIN SODIUM INJECTABLE;INJECTION 5,000 UNITS/100ML Prescription Yes Yes AP 1992/07/20 B BRAUN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database